Stay updated on Durvalumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.

Latest updates to the Durvalumab in Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedAn NIH funding note was added under the study IDs, detailing the 2018 U.S. NIH Grant/Contract support for the trial.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision label was bumped from v3.6.4 to v3.6.5, indicating a new build/version of the site. No content changes are evident.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new build of the site. This change does not modify the study details, layout, or other user-facing content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, indicating a recent update to the page's underlying version. This change represents a maintenance update rather than a modification to study content.SummaryDifference0.0%

- Check75 days agoChange DetectedA recruitment status notice 'No longer looking for participants' was added, along with new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a formatting update to the Intervention/Treatment header. The revision label was updated to Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision label on the page updated from v3.5.4 to v3.5.5. This updates the site version indicator rather than study content.SummaryDifference0.0%

Stay in the know with updates to Durvalumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.